Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a report issued on Thursday. The firm set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

NASDAQ CUTR opened at $0.51 on Thursday. The firm’s fifty day moving average price is $0.41 and its 200 day moving average price is $0.64. The company has a market capitalization of $10.29 million, a price-to-earnings ratio of -0.08 and a beta of 1.32. Cutera has a 12 month low of $0.28 and a 12 month high of $3.10.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings data on Thursday, November 7th. The medical device company reported ($1.94) EPS for the quarter, missing the consensus estimate of ($0.96) by ($0.98). The company had revenue of $32.50 million for the quarter, compared to analysts’ expectations of $32.57 million. During the same period last year, the business earned ($2.22) EPS. As a group, sell-side analysts forecast that Cutera will post -5.78 earnings per share for the current year.

Hedge Funds Weigh In On Cutera

An institutional investor recently raised its position in Cutera stock. Squarepoint Ops LLC lifted its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 164.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 113,964 shares of the medical device company’s stock after acquiring an additional 70,870 shares during the period. Squarepoint Ops LLC owned 0.57% of Cutera worth $172,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.